The effects of galanin on dorsal root ganglion neurons with high glucose treatment in vitro

Brain Research Bulletin

Volumn 87, Issue 1, 2012, Pages 85-93

  Xu, Xiaofeng ^a   Jiang, Hao ^b   Liu, Huaxiang ^b   Zhang, Weiwei ^a   Xu, Xiaobo ^c   Li, Zhenzhong ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dorsal root ganglion; Galanin; Glucose; Neuron

Indexed keywords

BETA ACTIN; CASPASE 3; GALANIN; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; GLUCOSE; MANNITOL; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; EMBRYO; ENERGY BALANCE; HOMEOSTASIS; IN VITRO STUDY; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SPINAL GANGLION; UPREGULATION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DIABETIC NEUROPATHIES; GALANIN; GANGLIA, SPINAL; GLUCOSE; HUMANS; NEURONS; RATS; RATS, WISTAR; RECEPTOR, GALANIN, TYPE 1; RECEPTOR, GALANIN, TYPE 2;

EID: 84155165113     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.10.012     Document Type: Article

References (59)

1. Abbosh C., Lawkowski A., Zaben M., Gray W. GalR2/3 mediates proliferative and trophic effects of galanin on postnatal hippocampal precursors. J. Neurochem. 2011, 117:425-436.
2. Abdel Nazeer A., Saito S., Sayed S., Hassan L., Askar F., Al-Jahdari W., Seki T., Hideaki O. Normal glucose enhances neuronal regeneration after lidocaine-induced injury. Br. J. Anaesth. 2010, 104:482-486.
3. Akude E., Zherebitskaya E., Chowdhury S.K., Smith D.R., Dobrowsky R.T., Fernyhough P. Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes 2011, 60:288-297.
4. Arnal E., Miranda M., Barcia J., Bosch-Morell F., Romero F.J. Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Neuroscience 2010, 166:271-278.
5. Berent-Spillson A., Russell J.W. Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. J. Neurochem. 2007, 101:342-354.
6. Bowser R., Kordower J.H., Mufson E.J. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol. 1997, 7:723-730.
7. Brumovsky P., Hygge-Blakeman K., Villar M.J., Watanabe M., Wiesenfeld-Hallin Z., Hokfelt T. Phenotyping of sensory and sympathetic ganglion neurons of a galanin-overexpressing mouse - possible implications for pain processing. J. Chem. Neuroanat. 2006, 31:243-262.
8. Calzà L., Pozza M., Zanni M., Manzini C.U., Manzini E., Hökfelt T. Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 1998, 82:575-589.
9. Cheng C., Zochodne D.W. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 2003, 52:2363-2371.
10. Cheng Y., Yu L.C. Galanin protects amyloid-beta-induced neurotoxicity on primary cultured hippocampal neurons of rats. J. Alzheimers Dis. 2010, 20:1143-1157.
11. Chowdhury S.K., Zherebitskaya E., Smith D.R., Akude E., Chattopadhyay S., Jolivalt C.G., Calcutt N.A., Fernyhough P. Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes 2010, 59:1082-1091.
12. Christianson J.A., Ryals J.M., Johnson M.S., Dobrowsky R.T., Wright D.E. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 2007, 145:303-313.
13. Coronel M.F., Brumovsky P.R., Hökfelt T., Villar M.J. Differential galanin upregulation in dorsal root ganglia and spinal cord after graded single ligature nerve constriction of the rat sciatic nerve. J. Chem. Neuroanat. 2008, 35:94-100.
14. Counts S.E., Chen E.Y., Che S., Ikonomovic M.D., Wuu J., Ginsberg S.D., Dekosky S.T., Mufson E.J. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2006, 21:205-214.
15. Counts S.E., He B., Che S., Ginsberg S.D., Mufson E.J. Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. J. Alzheimers Dis. 2009, 18:885-896.
16. Ding X., MacTavish D., Kar S., Jhamandas J.H. Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neurons. Neurobiol. Dis. 2006, 21:413-420.
17. Elliott-Hunt C.R., Holmes F.E., Hartley D.M., Perez S., Mufson E.J., Wynick D. Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2. J. Alzheimers Dis. 2011, 25:455-462.
18. Elliott-Hunt C.R., Marsh B., Bacon A., Pope R., Vanderplank P., Wynick D. Galanin acts as a neuroprotective factor to the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5105-5110.
19. Elliott-Hunt C.R., Pope R.J., Vanderplank P., Wynick D. Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage. J. Neurochem. 2007, 100:780-789.
20. Gaspar J.M., Castilho á., Baptista F.I., Liberal J., Ambrósio A.F. Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience 2010, 171:981-992.
21. Giannini S., Benvenuti S., Luciani P., Manuelli C., Cellai I., Deledda C., Pezzatini A., Vannelli G.B., Maneschi E., Rotella C.M., Serio M., Peri A. Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1). J. Endocrinol. 2008, 198:523-532.
22. Gumy L.F., Bampton E.T., Tolkovsky A.M. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol. Cell Neurosci. 2008, 37:298-311.
23. Hökfelt T., Tatemoto K. Galanin: a multitalented neuropeptide. EXS 2010, 102:1-5.
24. Holmes F.E., Mahoney S., King V.R., Bacon A., Kerr N.C., Pachnis V., Curtis R., Priestley J.V., Wynick D. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11563-11568.
25. Ji R.R., Zhang X., Zhang Q., Dagerlind A., Nilsson S., Wiesenfeld-Hallin Z., Hökfelt T. Central and peripheral expression of galanin in response to inflammation. Neuroscience 1995, 68:563-576.
26. Jiang L., Shi M., Guo L., He B., Li G., Zhang L., Zhang L., Shao H. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle. Neurosci. Lett. 2009, 467:178-181.
27. Jimenez-Andrade J.M., Zhou S., Yamani A., Valencia de Ita S., Castaneda-Hernandez G., Carlton S.M. Mechanism by which peripheral galanin increases acute inflammatory pain. Brain Res. 2005, 1056:113-117.
28. Kamiya H., Zhangm W., Sima A.A. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 2005, 54:3288-3295.
29. Kennedy J.M., Zochodne D.W. Heightened pain and delayed regeneration of galanin axons in diabetic mice. Neuroreport 2004, 15:807-810.
30. Kerekes N., Mennicken F., O'Donnell D., Hökfelt T., Hill R.H. Galanin increases membrane excitability and enhances Ca(2+) currents in adult, acutely dissociated dorsal root ganglion neurons. Eur. J. Neurosci. 2003, 18:2957-2966.
31. Landry M., Aman K., Dostrovsky J., Lozano A.M., Carlstedt T., Spenger C., Josephson A., Wiesenfeld-Hallin Z., Hökfelt T. Galanin expression in adult human dorsal root ganglion neurons: initial observations. Neuroscience 2003, 117:795-809.
32. Landry M., Liu H.X., Shi T.J., Brumovsky P., Nagy F., Hokfelt T. Galaninergic mechanisms at the spinal level: focus on histochemical phenotyping. Neuropeptides 2005, 39:223-231.
33. Leinninger G.M., Backus C., Sastry A.M., Yi Y.B., Wang C.W., Feldman E.L. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol. Dis. 2006, 23:11-22.
34. Lu C.L., Pasricha P.J., Hsieh J.C., Lu R.H., Lai C.R., Wu L.L., Chang F.Y., Lee S.D. Changes of the neuropeptides content and gene expression in spinal cord and dorsal root ganglion after noxious colorectal distension. Regul. Pept. 2005, 131:66-73.
35. Marrero J.A., Matkowskyj K.A., Yung K., Hecht G., Benya R.V. Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:797-804.
36. Matkowskyj K.A., Danilkovich A., Marrero J., Savkovic S.D., Hecht G., Benya R.V. Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens. Nat. Med. 2000, 6:1048-1051.
37. Matkowskyj K., Royan S.V., Blunier A., Hecht G., Rao M., Benya R.V. Age-dependent differences in galanin-dependent colonic fluid secretion after infection with Salmonella typhimurium. Gut 2009, 58:1201-1206.
38. McDonald M.P., Gleason T.C., Robinson J.K., Crawley J.N. Galanin inhibits performance on rodent memory tasks. Ann. N.Y. Acad. Sci. 1998, 863:305-322.
39. McMillan P.J., Peskind E., Raskind M.A., Leverenz J.B. Increased galanin receptor occupancy in Alzheimer's disease. Neurobiol. Aging 2004, 25:1309-1314.
40. Mufson E.J., Deecher D.C., Basile M., Izenwasse S., Mash D.C. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 2000, 39:1404-1412.
41. O'Meara G., Coumis U., Ma S.Y., Kehr J., Mahoney S., Bacon A., Allen S.J., Holmes F., Kahl U., Wang F.H., Kearns I.R., Ove-Ogren S., Dawbarn D., Mufson E.J., Davies C., Dawson G., Wynick D. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11569-11574.
42. Oztürk G., Erdoĝan E., Oztürk M., Cengiz N., Him A. Differential analysis of effect of high glucose level in the development of neuropathy in a tissue culture model of diabetes mellitus: role of hyperosmolality. Exp. Clin. Endocrinol. Diabetes 2008, 116:582-591.
43. Pérez S., Basile M., Mash D.C., Mufson E.J. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. J. Chem. Neuroanat. 2002, 24:109-1016.
44. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J. 2002, 16:1738-1748.
45. Shi T.J., Hua X.Y., Lu X., Malkmus S., Kinney J., Holmberg K., Wirz S., Ceccatelli S., Yaksh T., Bartfai T., Hokfelt T. Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. Eur. J. Neurosci. 2006, 23:627-636.
46. Shimoshige Y., Minoura K., Matsuoka N., Takakura S., Mutoh S., Kamijo M. Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats. Brain Res. 2009, 1247:182-187.
47. Simpson J., Sundler F., Humes D.J., Jenkins D., Wakelin D., Scholefield J.H., Spiller R.C. Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis. Neurogastroenterol. Motil. 2008, 20:392-406.
48. Srinivasan S., Stevens M., Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000, 49:1932-1938.
49. Sten Shi T.J., Zhang X., Holmberg K., Xu Z.Q., Hökfelt T. Expression and regulation of galanin-R2 receptors in rat primary sensory neurons: effect of axotomy and inflammation. Neurosci. Lett. 1997, 237:57-60.
50. Tomlinson D.R., Gardiner N.J. Glucose neurotoxicity. Nat. Rev. Neurosci. 2008, 9:36-45.
51. Villar M.J., Cortés R., Theodorsson E., Wiesenfeld-Hallin Z., Schalling M., Fahrenkrug J., Emson P.C., Hökfelt T. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 1989, 33:587-604.
52. Vincent A.M., Edwards J.L., McLean L.L., Hong Y., Cerri F., Lopez I., Quattrini A., Feldman E.L. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol. 2010, 120:477-489.
53. Waters S.M., Krause J.E. Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 2000, 95:265-271.
54. Wilson-Gerwing T.D., Verge V.M. Neurotrophin-3 attenuates galanin expression in the chronic constriction injury model of neuropathic pain. Neuroscience 2006, 141:2075-2085.
55. Wrenn C.C., Crawley J.N. Pharmacological evidence supporting a role for galanin in cognition and affect. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:283-299.
56. Xu Z.Q., Shi T.J., Landry M., Hökfelt T. Evidence for galanin receptors in primary sensory neurones and effect of axotomy and inflammation. Neuroreport 1996, 8:237-242.
57. Zherebitskaya E., Akude E., Smith D.R., Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 2009, 58:1356-1364.
58. Zochodne D.W., Verge V.M., Cheng C., Sun H., Johnston J. Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 2001, 124:2319-2334.
59. Zorrilla E.P., Brennan M., Sabino V., Lu X., Bartfai T. Galanin type 1 receptor knockout mice show altered responses to high-fat diet and glucose challenge. Physiol. Behav. 2007, 91:479-485.